FRED Retrospective Study of Intracranial Aneurysms Treatment

A Retrospective Post-Market Clinical Study of the Flow Re-Direction Endoluminal Device System in the Treatment of Intracranial Aneurysms

To evaluate the long-term safety and efficacy of Flow Re-Direction Endoluminal Device System (FRED) in the treatment of intracranial aneurysms in the post-market environment

Study Objective: To evaluate the long-term safety and efficacy of Flow Re-Direction Endoluminal Device System (FRED) in the treatment of intracranial aneurysms in the post-market.

Study Design: Post-market, retrospective, multi-center, observational clinical study Study Population: Patient who has implanted at least one observational device in China mainland.

Inclusion Criteria:

• People in China mainland who have been treated with FRED. The patients for whom clinical data are available

Exclusion Criteria:

• Patients who met the inclusion criteria at all time points were required to be included in the study. Therefore, no specific exclusion criteria were set.